MENU
BCYC
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Bicycle Therapeutics (BCYC) Ownership - Who owns Bicycle Therapeutics?

Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles... Show more

Profile

Industry
N/A
Address
Granta Park, Great Abington
Phone
+44 1223261503
Employees
284
Web
https://www.bicycletherapeutics.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
577.58M
P/E Ratio
N/A
Total Cash
792.97M
Projected Growth
N/A
Total Debt
8.33M
Revenue
25.72M
Risk (Beta)
1.40
Dividend Yield
N/A
Total Cash/Share
11.45
Total Debt/Equity
N/A
Revenue/Share
0.40 USD as % of share price

Fundamentals

BCYC
Capitalization
578M
P/E Ratio
N/A
Risk (Beta)
1.40
Dividend Yield
N/A
Total Cash
793M
Total Cash/Share
11.45
Total Debt
8.33M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.40%
Revenue
25.7M
ROE
N/A
Book Value
740M
P/B Ratio
0.78
Cash Flow
N/A
Earnings
-3.16
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
892K
Current Ratio
14.86
Current Revenue Per Employee
32711.47
Dividends Per Share - Security
N/A
EBITDA
-200.61M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-28.40
Shares Held By Institutions
630M
Shares Outstanding - Current
69.3M
Total Liabilities
144M
Total Volume MTD
N/A
Value
1
Gain YTD
-40.429
View a ticker or compare two or three
BCYC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a holding company, which engages in the development of biopharmaceuticals.

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
Granta Park, Great Abington
Phone
+44 1223261503
Employees
284
Web
https://www.bicycletherapeutics.com